2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation. 2014 Jun 24; 129(25 Suppl 2):S1-45.Circ
Links
MeSH
Pub Type(s)
Journal Article
Practice Guideline
Language
eng
PubMed ID
24222016
Clinical Trial Links
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy
Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy
Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis
Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen
Citation
Stone, Neil J., et al. "2013 ACC/AHA Guideline On the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a Report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines." Circulation, vol. 129, no. 25 Suppl 2, 2014, pp. S1-45.
Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1-45.
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., McBride, P., Schwartz, J. S., Shero, S. T., Smith, S. C., Watson, K., Wilson, P. W., Eddleman, K. M., Jarrett, N. M., LaBresh, K., ... Tomaselli, G. F. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(25 Suppl 2), S1-45. https://doi.org/10.1161/01.cir.0000437738.63853.7a
Stone NJ, et al. 2013 ACC/AHA Guideline On the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a Report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. PubMed PMID: 24222016.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
AU - Stone,Neil J,
AU - Robinson,Jennifer G,
AU - Lichtenstein,Alice H,
AU - Bairey Merz,C Noel,
AU - Blum,Conrad B,
AU - Eckel,Robert H,
AU - Goldberg,Anne C,
AU - Gordon,David,
AU - Levy,Daniel,
AU - Lloyd-Jones,Donald M,
AU - McBride,Patrick,
AU - Schwartz,J Sanford,
AU - Shero,Susan T,
AU - Smith,Sidney C,Jr
AU - Watson,Karol,
AU - Wilson,Peter W F,
AU - Eddleman,Karen M,
AU - Jarrett,Nicole M,
AU - LaBresh,Ken,
AU - Nevo,Lev,
AU - Wnek,Janusz,
AU - Anderson,Jeffrey L,
AU - Halperin,Jonathan L,
AU - Albert,Nancy M,
AU - Bozkurt,Biykem,
AU - Brindis,Ralph G,
AU - Curtis,Lesley H,
AU - DeMets,David,
AU - Hochman,Judith S,
AU - Kovacs,Richard J,
AU - Ohman,E Magnus,
AU - Pressler,Susan J,
AU - Sellke,Frank W,
AU - Shen,Win-Kuang,
AU - Smith,Sidney C,Jr
AU - Tomaselli,Gordon F,
AU - ,,
Y1 - 2013/11/12/
PY - 2013/11/14/entrez
PY - 2013/11/14/pubmed
PY - 2014/10/1/medline
KW - AHA Scientific Statements
KW - biomarkers, pharmacological
KW - cardiovascular disease
KW - cholesterol
KW - diabetes mellitus
KW - drug therapy
KW - hydroxymethylglutaryl-CoA reductase inhibitors/statins
KW - hypercholesterolemia
KW - lipids
KW - patient compliance
KW - primary prevention
KW - risk assessment
KW - risk reduction behavior
KW - secondary prevention
SP - S1
EP - 45
JF - Circulation
JO - Circulation
VL - 129
IS - 25 Suppl 2
SN - 1524-4539
UR - https://www.unboundmedicine.com/medline/citation/24222016/full_citation
DB - PRIME
DP - Unbound Medicine
ER -
